Dentsply Sirona stock (US24906P1093): dental specialist updates 2026 guidance after solid quarter

Dentsply Sirona has updated its 2026 financial targets following a solid start to the year and progress on its efficiency program. The dental technology group remains under the spotlight as investors weigh growth in implants and clear aligners against cost pressures.

Dentsply Sirona has refined its medium-term outlook after reporting a solid start to 2024 and outlining new financial targets through 2026 for its dental equipment and consumables business, according to a presentation published with its first-quarter 2024 results on May 2, 2024, and subsequent investor communications in early 2025 Dentsply Sirona investor update as of 05/02/2024. The company emphasized continued margin improvement, disciplined capital allocation and targeted innovation in areas such as imaging, CAD/CAM and clear aligners as key levers for achieving its updated 2026 goals.

In its first-quarter 2024 earnings release, Dentsply Sirona reported net sales of roughly $953 million for the period ended March 31, 2024, and adjusted earnings per share from continuing operations of $0.42, highlighting progress on profitability initiatives in North America and Europe while acknowledging ongoing macroeconomic headwinds, according to company disclosures on May 2, 2024 Dentsply Sirona Q1 2024 report as of 05/02/2024. Management also reaffirmed its full-year 2024 guidance at that time and linked its 2026 ambitions to continued execution on its restructuring program and investments in digital workflows.

As of: 16.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Dentsply Sirona Inc
• Sector/industry: Dental equipment and consumables, medical technology
• Headquarters/country: Charlotte, North Carolina, United States
• Core markets: North America, Europe, Asia-Pacific dental practices and laboratories
• Key revenue drivers: Imaging systems, CAD/CAM solutions, endodontic and restorative products, implants and clear aligners
• Home exchange/listing venue: Nasdaq (ticker: XRAY)
• Trading currency: US dollar (USD)

Dentsply Sirona: core business model

Dentsply Sirona describes itself as a leading provider of professional dental products and technologies, offering a broad portfolio that spans equipment, instruments and consumables for dentists and dental laboratories worldwide. The group’s business is oriented around enabling clinical workflows from diagnostics to treatment and follow-up, with a focus on restorative, endodontic, orthodontic and implantology applications, according to its corporate profile updated in 2024 Dentsply Sirona company overview as of 03/2024. By combining hardware, software and materials, the company aims to create integrated solutions that help practitioners improve efficiency and patient outcomes.

The business is typically reported in major segments that include Technologies & Equipment along with Consumables or Specialty Products, reflecting the different nature of capital equipment versus recurring materials demand. Technologies & Equipment covers areas such as imaging systems, treatment centers and chairside CAD/CAM units, while consumable categories encompass restorative materials, endodontic products, preventive solutions and orthodontic offerings including clear aligners, as outlined in the company’s 2023 Form 10-K filed in February 2024 Dentsply Sirona 2023 Form 10-K as of 02/29/2024. This mix provides exposure to both replacement cycles for equipment and more stable demand patterns for consumables.

Revenue is generated primarily through shipments to dental distributors and, to a lesser extent, direct sales to large dental chains and laboratories in key markets such as the United States, Germany and China. The company notes that its installed base of equipment supports pull-through demand for proprietary materials and software, anchoring long-term relationships with practitioners and clinics, according to its annual report for 2023 published in late February 2024. The model therefore combines up-front equipment sales that can be cyclical with recurring revenue streams that are tied to procedure volume in general dentistry and specialty care.

Main revenue and product drivers for Dentsply Sirona

One of the most important revenue drivers for Dentsply Sirona is its portfolio of imaging and CAD/CAM systems, including intraoral scanners, cone-beam computed tomography units and chairside milling machines. These technologies support digital dentistry workflows, allowing dentists to capture 3D images, design restorations on-screen and fabricate crowns, bridges or veneers in-house. Management has highlighted growing adoption of digital workflows by dental practices in North America and Europe as a structural tailwind, according to its 2023 annual report filed in February 2024 Dentsply Sirona 2023 Form 10-K as of 02/29/2024. Upgrades to imaging fleets and software subscriptions can support recurring revenue over time.

Consumables and specialty products form another major pillar. In restorative dentistry, the company sells composites, bonding agents, cements and other materials used day-to-day in general dental practice, while its endodontic portfolio includes root canal instruments and filling materials. The 2023 Form 10-K notes that restorative and endodontic solutions together represent a significant share of revenue, driven by the high frequency of fillings and root canal procedures in mature markets. Meanwhile, specialty areas such as dental implants and clear aligners provide exposure to higher-growth segments as patients seek esthetic and functional improvements, according to the same filing in February 2024.

Dentsply Sirona has also emphasized its focus on innovation pipeline and commercialization as a driver of future sales. Product updates in 2023 and early 2024 included enhancements to digital imaging software, new implant system components and expansions of its clear aligner offering, aimed at both orthodontists and general dentists, according to its 2023 annual report and product releases compiled in 2024. The company believes that combining clinical education programs with new product launches can help accelerate adoption, particularly in markets where digital dentistry is still in earlier stages.

Conclusion

Dentsply Sirona stands at the intersection of medical technology and dental practice management, combining capital equipment with consumables and software-driven workflows. Recent financial updates and its articulated 2026 targets underline management’s focus on margin expansion, disciplined investment and broadening the company’s footprint in digital dentistry. For US investors, the stock offers exposure to procedure-driven demand in the United States and internationally, as well as to structural trends such as aging populations and growing interest in esthetic dentistry. At the same time, the business remains sensitive to capital spending cycles in clinics, regulatory environments and competitive dynamics across implants, clear aligners and imaging systems, which investors may monitor closely as Dentsply Sirona executes on its strategy.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.